Brookside invests in SummitReheis

Brookside Mezzanine Partners has made an undisclosed investment in SummitReheis, a portfolio company of One Rock Capital Partners. Based in Huguenot, NY, Summit is a maker of active ingredients for antiperspirants.


Yukon Partners supports One Rock Capital’s investment in Airxcel

Yukon Partners has invested subordinated debt and equity in One Rock Capital Partners’ investment in Airxcel, Inc., which makes climate control products, including air conditioners, heat pumps, cooking appliances and furnaces. Along with Yukon, subordinated debt was provided by Freedom 3 Capital and Babson Capital Management. Senior financing was provided by GE Antares Capital and Citizens Financial Group. Specific terms of the deal were not disclosed.


One Rock Capital Partners closes $431.5 mln for debut fund

Lower middle-market private equity firm One Rock Capital Partners has raised $431.5 million in the final close of its initial fund. The target was $300 million. The fund’s LPs include government and corporate pension plans, insurance companies and health organizations. Greenhill & Co. was the placement agent.

HYCOR Biomedical Sells Urinalysis Business

HYCOR Biomedical, a manufacturer and marketer of in vitro diagnostic products for the global allergy and autoimmune markets, has sold its urinalysis business to an affiliate of One Rock Capital Partners, Laurel Crown Partners, and StoneCreek Capital. HYCOR is a portfolio company of Linden Capital Partners.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget